The place of bleomycin in the treatment of highly differentiated squamous cell cancer either alone or in combination with irradiation.
D001761:Bleomycin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000532:radiotherapy / Q000628:therapy*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004341:Drug Evaluation; D004848:Epithelium; D006258:Head and Neck Neoplasms / Q000188:drug therapy / Q000532:radiotherapy; D006801:Humans; D007249:Inflammation / Q000139:chemically induced; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D007822:Laryngeal Neoplasms / Q000628:therapy; D008171:Lung Diseases / Q000139:chemically induced; D012075:Remission, Spontaneous
D001761:Bleomycin